Angeles Investment Advisors’s Gilead Sciences GILD Stock Holding History

Angeles Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,114	Closed	-$228K	–	226
2024 Q1	$228K	Sell	3,114 -226	-7%	-$17.4K	0.01%	195
2023 Q4	$271K	Buy	3,340 +35	+1%	+$2.72K	0.02%	161
2023 Q3	$248K	Sell	3,305 -4,420	-57%	-$340K	0.02%	154
2023 Q2	$595K	Buy	7,725 +5,002	+184%	+$399K	0.05%	51
2023 Q1	$226K	Buy	+2,723	New	+$226K	0.02%	140
2022 Q3	–	Sell	-3,695	Closed	-$228K	–	76
2022 Q2	$228K	Hold	3,695	–	–	0.02%	96
2022 Q1	$220K	Sell	3,695 -638	-15%	-$40.8K	0.02%	113
2021 Q4	$315K	Buy	4,333 +638	+17%	+$43.9K	0.02%	168
2021 Q3	$258K	Buy	+3,695	New	+$260K	0.02%	186

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Angeles Investment Advisors's GILD Position: Q2 2024 in Review

Angeles Investment Advisors sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 3,114 shares — an estimated $228K sold.

Angeles Investment Advisors first reported a position in GILD in Q3 2021 and held it in 9 quarters. The position peaked at $595K in Q2 2023. 1,679 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

Angeles Investment Advisors reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
Angeles Investment Advisors sold 3,114 Gilead Sciences shares in Q2 2024, an estimated $228K.
Angeles Investment Advisors first reported a position in Gilead Sciences in Q3 2021 and held it in 9 quarters.
Angeles Investment Advisors's Gilead Sciences position peaked at $595K in Q2 2023.
1,679 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Angeles Investment Advisors's 13F filing for Q2 2024, filed 9 Aug 2024.